234
Participants
Start Date
February 1, 2018
Primary Completion Date
February 28, 2019
Study Completion Date
February 28, 2019
Intervention Group
"The goal of this research study is to evaluate the preliminary impact of a public-health-partnered tele-pharmacist model for pre-exposure prophylaxis (PrEP) delivery in a rural state (TelePrEP). In brief, PrEP involves daily use of a medication (i.e. Truvada) to prevent HIV infection among people at risk for infection due to sexual exposure or needle sharing."
University of Iowa Hospitals and Clinics, Iowa City
Collaborators (1)
Gilead Sciences
INDUSTRY
Michael Ohl
OTHER